Marshall Wace’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Marshall Wace’s Portfolio PEPL Stock Details PEPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-748,549	Closed	-$7.65M	–	3292
2022 Q4	$7.65M	Hold	748,549	–	–	0.02%	948
2022 Q3	$7.48M	Hold	748,549	–	–	0.02%	1091
2022 Q2	$7.46M	Hold	748,549	–	–	0.02%	1072
2022 Q1	$7.34M	Hold	748,549	–	–	0.01%	1095
2021 Q4	$7.34M	Buy	+748,549	New	+$7.31M	0.01%	1095

Other funds holding PEPL

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Marshall Wace's PEPL Position: Q1 2023 in Review

Marshall Wace sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 748,549 shares — an estimated $7.65M sold.

Marshall Wace first reported a position in PEPL in Q4 2021 and held it in 5 quarters. The position peaked at $7.65M in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

Marshall Wace reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Marshall Wace sold 748,549 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $7.65M.
Marshall Wace first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Marshall Wace's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $7.65M in Q4 2022.
15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.